USCOM LIMITED — Regulatory Filings 2011

Apr 12, 2011

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

M A R K E T A N N O U N C E M E N T

Ucsom secures Inspired Medical Systems in US and strong presence in Canada

Uscom Ltd (ASX code UCM) announce the appointment of US medical device distributor Inspired Medical Systems (IMS).

IMS is based in Newhampshire and this appointment secures a highly reputable distributor covering hospitals in the north east states of USA.

Uscom also announces the appointment of two distributors in the Canadian market. Caster Medical Systems based in Toronto and Braemed Limited based in Dartmouth, Nova Scotia. This brings the total coverage of the North American hospital market to 80% with agreements in principle for the remaining 20% from distributors still under negotiation.

All three distributors are well acquainted with servicing hospitals with ground breaking new medical devices and have committed to leveraging their established client sites and networks on behalf of Uscom to build Uscom’s presence in these important markets.

Uscom’s Executive Chairman, Mr Phil Kiely said, “I have now personally met all our new distributors in the North American market and am confident that they will quickly begin to produce sound sales results for the business. Each have been carefully selected for their sales capabilities in Uscom’s hospital markets in Pediatrics, Intensive care and Emergency departments. We are excited that IMS, Caster and Braemed have joined us in helping to establish Uscom as the leader in non invasive Haemodynamic management.

About Uscom

Uscom Limited is an Australian medical device company which was first listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor which measures critical performance indicators of haemodynamics. The USCOM 1A is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency Medicine, Intensive Care Units and Anesthesia, and is a potential new standard in the management of adult and paediatric sepsis, and for the guidance of all fluid and drug therapy administration. USCOM has global regulatory approval and the technology is currently marketed in North America, South America, Europe, the Middle East, India and Australia & New Zealand through its distributors in Asia .

Uscom Contacts Phil Kiely Executive Chairman phil.kiely@uscom.com.au

Daniel Fah Company Secretary daniel.fah@uscom.com.au